https://orcid.org/0000-0002-0441-7247
Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Ebrahim Ghasemy, Ahmad Miri Jahromi, Mohammad Khedri, Pegah Zandi, Reza Maleki & Lobat Tayebi. (2022) In-silico study on viability of MXenes in suppressing the coronavirus infection and distribution. Journal of Biomolecular Structure and Dynamics 40:21, pages 11460-11466.
Read now
Read now
Articles from other publishers (19)
Anna-Maria Herzog, Katharina Göbel, Luigi Marongiu, Natalia Ruetalo, Marta Campos Alonso, Christian Leischner, Christian Busch, Markus Burkard, Ulrich M. Lauer, Paul P. Geurink, Klaus-Peter Knobeloch, Michael Schindler, Günter Fritz & Sascha Venturelli. (2024) Compounds derived from Humulus lupulus inhibit SARS-CoV-2 papain-like protease and virus replication. Phytomedicine 123, pages 155176.
Crossref
Crossref
Alejandra García-Aguilar, Rebeca Campi-Caballero, Giovani Visoso-Carvajal, José Rubén García-Sánchez, José Correa-Basurto, Jazmín García-Machorro & Judith Espinosa-Raya. (2023) In Vitro Analysis of SARS-CoV-2 Spike Protein and Ivermectin Interaction. International Journal of Molecular Sciences 24:22, pages 16392.
Crossref
Crossref
Fuxiang Wang, Wen Xiao, Yimin Tang, Mengli Cao, Dan Shu, Tetsuya Asakawa, Yechun Xu, Xiangrui Jiang, Leike Zhang, Wei Wang, Jianxing Tang, Yuansheng Huang, Yang Yang, Yumei Yang, Renhong Tang, Jingshan Shen & Hongzhou Lu. (2023) Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial. The Lancet Regional Health - Western Pacific 38, pages 100835.
Crossref
Crossref
Bandhan Sarker, Md. Matiur Rahaman, Md. Ariful Islam, Muhammad Habibulla Alamin, Md. Maidul Husain, Farzana Ferdousi, Md. Asif Ahsan & Md. Nurul Haque Mollah. (2023) Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections. PLOS ONE 18:3, pages e0281981.
Crossref
Crossref
Ajay Manaithiya, Ozair Alam, Shruti Mittal, Mohd. Javed Naim, Mohd. Imran, Ahmed Subeh Alshrari, Aadil A. Sheikh & Imran A. Khan. (2023) An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV
and SARS-CoV-2 3CLpro. Mini-Reviews in Medicinal Chemistry 23:5, pages 576-632.
Crossref
Crossref
Izabela Szczesniak, Agnieszka Baliga-Gil, Aleksandra Jarmolowicz, Marta Soszynska-Jozwiak & Elzbieta Kierzek. (2023) Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors. International Journal of Molecular Sciences 24:2, pages 1232.
Crossref
Crossref
Prabhat Ranjan, Kumar Gaurav & Tanmoy Chakraborty. (2022) Computational study of some potential inhibitors of COVID‐19: A DFT analysis. Quantitative Biology 10:4, pages 341-350.
Crossref
Crossref
Saloni, Dimple Kumari, Prabhat Ranjan & Tanmoy Chakraborty. (2022) A computational study of potential therapeutics for COVID-19 invoking conceptual density functional theory. Structural Chemistry 33:6, pages 2195-2204.
Crossref
Crossref
Dhruv Chauhan, Nikhil Chakravarty, Arjit Vijey Jeyachandran, Akshaya Jayakarunakaran, Sanjeev Sinha, Rakesh Mishra, Vaithilingaraja Arumugaswami & Arunachalam Ramaiah. (2022) In Silico Genome Analysis Reveals the Evolution and Potential Impact of SARS-CoV-2 Omicron Structural Changes on Host Immune Evasion and Antiviral Therapeutics. Viruses 14:11, pages 2461.
Crossref
Crossref
Sarya Swed, Sheikh Shoib, Mohammad B. Almoshantaf, Walaa Hasan, Yomna E. Dean, Yousef Tanas, Haidara Bohsas, Hidar Alibrahim, Mohammad M. Hasan, Weaam Ezzdean, Hazem S. Ghaith, Lina T. Khairy, Agyad Bakkour, Ali Hadi Hussein Muwaili, Fatima A. A. Abdelmajid, Mhd K. Albuni, Elias Battikh, Dhuha Hadi Hussein Muwaili, Rima Qattea, Karam R. Motawea, Bisher Sawaf, Nashaat Kamal Hamdy Elkalagi, Safaa M. A. Ahmed & Hani Aiash. (2022) Knowledge, attitudes, and practices related to COVID‐19 infection, related behavior, antibiotics usage, and resistance among Syrian population: A cross‐sectional study. Health Science Reports 5:6.
Crossref
Crossref
Ebrahim Mostafavi, Siavash Iravani & Rajender S. Varma. (2022) Nanosponges: An overlooked promising strategy to combat SARS-CoV-2. Drug Discovery Today 27:10, pages 103330.
Crossref
Crossref
Gabriela León-Gutiérrez, James Edward Elste, Carlos Cabello-Gutiérrez, Cesar Millán-Pacheco, Mario H. Martínez-Gómez, Rafael Mejía-Alvarez, Vaibhav Tiwari & Armando Mejía. (2022) A potent virucidal activity of functionalized TiO2 nanoparticles adsorbed with flavonoids against SARS-CoV-2. Applied Microbiology and Biotechnology 106:18, pages 5987-6002.
Crossref
Crossref
Sushma Thapa, Kshitij RB Singh, Ranjana Verma, Jay Singh & Ravindra Pratap Singh. (2022) State-of-the-Art Smart and Intelligent Nanobiosensors for SARS-CoV-2 Diagnosis. Biosensors 12:8, pages 637.
Crossref
Crossref
Nastaran Barati, Seyedmousa Motavallihaghi, Banafsheh Nikfar, Shahla Chaichian & Amir Abbas Momtazi-Borojeni. (2022) Potential therapeutic effects of Ivermectin in COVID-19. Experimental Biology and Medicine 247:15, pages 1388-1396.
Crossref
Crossref
Navid Rabiee, Sepideh Ahmadi, Ghazaleh Jamalipour Soufi, Ali Hekmatnia, Mehrdad Khatami, Yousef Fatahi, Siavash Iravani & Rajender S Varma. (2022)
Quantum dots against
SARS‐CoV
‐2: diagnostic and therapeutic potentials
. Journal of Chemical Technology & Biotechnology 97:7, pages 1640-1654.
Crossref
Crossref
Baisen Zhong, Weiyu Peng, Shan Du, Bingyi Chen, Yajuan Feng, Xinfeng Hu, Qi Lai, Shujie Liu, Zhong-Wei Zhou, Pengfei Fang, Yan Wu, Feng Gao, Huihao Zhou & Litao Sun. (2022) Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease. Small Science 2:6, pages 2100124.
Crossref
Crossref
Zheng Yao Low, Ashley Jia Wen Yip & Sunil K. Lal. (2022) Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:2, pages 166294.
Crossref
Crossref
Ghazaleh Jamalipour Soufi, Siavash Iravani & Rajender S. Varma. (2021) Molecularly imprinted polymers for the detection of viruses: challenges and opportunities. The Analyst 146:10, pages 3087-3100.
Crossref
Crossref
David Livingstone Alves Figueiredo, João Paulo Bianchi Ximenez, Fábio Rodrigues Ferreira Seiva, Carolina Panis, Rafael dos Santos Bezerra, Adriano Ferrasa, Alessandra Lourenço Cecchini, Alexandra Ivo de Medeiros, Ana Marisa Fusco Almeida, Anelisa Ramão, Angelica Beate Winter Boldt, Carla Fredrichsen Moya, Chung Man Chin, Daniel de Paula, Daniel Rech, Daniela Fiori Gradia, Danielle Malheiros, Danielle Venturini, Eliandro Reis Tavares, Emerson Carraro, Enilze Maria de Souza Fonseca Ribeiro, Evani Marques Pereira, Felipe Francisco Tuon, Franciele Aní Caovilla Follador, Glaura Scantamburlo Alves Fernandes, Hélito Volpato, Ilce Mara de Syllos Cólus, Jaqueline Carvalho de Oliveira, Jean Henrique da Silva Rodrigues, Jean Leandro dos Santos, Jeane Eliete Laguila Visentainer, Juliana Cristina Brandi, Juliana Mara Serpeloni, Juliana Sartori Bonini, Karen Brajão de Oliveira, Karine Fiorentin, Léia Carolina Lucio, Ligia Carla Faccin-Galhardi, Lirane Elize Defante Ferreto, Lucy Megumi Yamauchi Lioni, Marcia Edilaine Lopes Consolaro, Marcelo Ricardo Vicari, Marcos Abdo Arbex, Marcos Pileggi, Maria Angelica Ehara Watanabe, Maria Antônia Ramos Costa, Maria José S. Mendes Giannini, Marla Karine Amarante, Najeh Maissar Khalil, Quirino Alves de Lima Neto, Roberto H. Herai, Roberta Losi Guembarovski, Rogério N. Shinsato, Rubiana Mara Mainardes, Silvana Giuliatti, Sueli Fumie Yamada-Ogatta, Viviane Knuppel de Quadros Gerber, Wander Rogério Pavanelli, Weber Claudio da Silva, Maria Luiza Petzl-Erler, Valeria Valente, Christiane Pienna Soares, Luciane Regina Cavalli & Wilson Araujo Silva Jr. (2021) COVID-19: The question of genetic diversity and therapeutic intervention approaches. Genetics and Molecular Biology 44:1 suppl 1.
Crossref
Crossref